Advisory Services Network, LLC Catalyst Pharmaceuticals, Inc. Transaction History

Advisory Services Network, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$11.78 - $17.29 $5,890 - $8,645	500 New	500 $8,000
Q1 2023 May 17, 2023	BUY	$14.34 - $21.05 $18,656 - $27,386	1,301 Added 260.2%	1,801 $29,000
Q4 2022 Feb 13, 2023	BUY	$12.25 - $19.5 $6,125 - $9,750	500 New	500 $9,000
Q4 2020 Feb 09, 2021	SELL	$2.97 - $3.83 $1,188 - $1,532	-400 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$2.97 - $5.08 $1,188 - $2,032	400 New	400 $1,000

326

94.6M

19.1K

51.1K

Ticker CPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 102,820,000
Market Cap $2.12B
Description
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

Stay updated on Advisory Services Network, LLC with notifications on news.